Drug Discovery

An intensive 2-day in person meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development. From new and exciting to the latest in products & services, this event will bring together over 150 leading companies for in-depth discussions, knowledge sharing and focused networking. Colocated with the RNA Therapeutics & Delivery Europe: In Person.

Discover the latest tools and strategies for advanced organ model development. Featuring key case studies on the application of organoid and organ-on-a-chip models in disease modelling, drug discovery and predictive diagnostics. From exploratory techniques through to proven preclinical methods, benefit from the expertise of leading academic, pharmaceutical, and solution oriented speakers, sharing the latest developments for the creation of complex, scalable organ models.

Discover the latest tools and strategies for advanced organ model development. Featuring key case studies on the application of organoid and organ-on-a-chip models in disease modelling, drug discovery and predictive diagnostics. From exploratory techniques through to proven preclinical methods, benefit from the expertise of leading academic, pharmaceutical, and solution oriented speakers, sharing the latest developments for the creation of complex, scalable organ models.

he Antibody Society members serve as Scientific Advisors and Session Chairs for Antibody Engineering & Therapeutics Europe. Antibody Engineering & Therapeutics conferences are our premier forums for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders. For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs. We look forward to seeing you in Amsterdam!

This year’s event will feature world-renowned speakers, cutting-edge technologies, and engaging networking events. Programming includes in-depth coverage of antibody discovery, protein engineering, bispecific antibodies, emerging immunotherapies, protein aggregation, machine learning, cell and gene therapy, protein expression, purification and production.

AAPS is the convener of the pharmaceutical science community, bringing together thousands of scientists from across the world and the drug development process. For them, PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a small niche meeting because of its unique programming structure.

The National Biotechnology Conference (NBC) brings together hundreds of pharmaceutical professionals from industry, academia, and regulatory organizations who are seeking innovative solutions, insight into new emerging trends, and collaborative opportunities within the biotech community.

This unique event brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotide and precision therapeutics throughout the drug development process.

The triennial World Parkinson Congresses provide an international forum for basic scientists, clinical researchers, health care professionals, people with Parkinson’s and others to come together under one roof to discuss, learn, and engage in debate around the latest scientific discoveries, medical and comprehensive care practices related to Parkinson’s disease.

A dedicated virtual congress for pharmaceutical manufacturing experts. The event will attract attendees representing pharmaceutical companies working in pharma manufacturing, automation & robotics as well as supply chain & sustainable manufacturing.